Nearly half of US rheumatologists expect Gazyva to meaningfully reshape SLE treatment pathways, while CAR T-cell therapy is ...

A research team of Professor Yoontae Lee and Jiho Park, a PhD candidate, from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) recently discovered that a ...

New data identify age, anti-β2GP1 antibodies, and low C3 as key risk factors for cerebral small vessel disease in systemic ...

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease driven by both genetic susceptibility and environmental risk factors. Epigenetic processes, which lie at the intersection of ...

Please provide your email address to receive an email when new articles are posted on . “These findings suggest that IFN-I blocking agents may be particularly effective in treating skin manifestations ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular disease is a leading cause of mortality in systemic lupus erythematosus. Controlling SLE disease ...

The trial met its primary composite endpoint demonstrating significant clinical improvement with dapirolizumab pegol vs placebo in patients with moderate to severe SLE. Topline results were announced ...

Dr. Hui-Chen Hsu is Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology. Dr. Hsu collaborated with Drs. John D. Mountz, Hao Li, Jun Li, Yong Zhou, David Crossman, ...